- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
A new study from researchers at the University of Toronto’s Sunnybrook Research Institute suggests that zinc may be useful in treating depression.
It’s well known that zinc is critical to the healthy operation of the human immune system — put simply, the base metal allows the body to respond properly to infectious diseases. However, an article published recently in Biological Psychiatry suggests that zinc may also be useful in treating depression.
“A growing body of evidence demonstrates that experimental zinc deficiency can induce depressive-like behavior in animals, which can be effectively reversed by zinc supplementation,” Psych Central quotes the authors, all from the Sunnybrook Research Institute at the University of Toronto, as saying.
The team came to that conclusion after analyzing 17 studies that together measure blood-zinc concentrations in 1,643 depressed patients and 804 control participants, Psych Central explains. Psychiatric inpatients were involved in 10 of those studies, while seven involved community samples.
While the authors note that “association studies cannot determine the direction of causation, a causal association between zinc status and depression is biologically plausible.” That’s due in part to zinc’s role in the immune system, as well as its antioxidant properties and “multiple roles in regulating [brain circuits] and cognitive function.”
As a result, they believe the relationship between “zinc status and depression” should be looked into further, as should the “potential benefits of zinc supplementation in depressed patients.”
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Related reading:
Zinc’s Health Benefits Not to be Overlooked
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.